Innate immunity in latent autoimmune diabetes in adults. Issue 1 (22nd June 2021)

• Record Type: Journal Article
• Authors: Huang, Juan; Pearson, James Alexander; Wong, F. Susan; Wen, Li; Zhou, Zhiguang
• Is Part Of: Diabetes/metabolism research and reviews. Volume 38:Issue 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-22
• Subjects: autoimmune -- diabetes mellitus -- innate immune cells -- innate immunity -- latent autoimmune diabetes in adults; Diabetes -- Periodicals; Metabolism -- Periodicals; 616.642
• DOI: 10.1002/dmrr.3480
• Languages: English
• ISSNs: 1520-7552

Abstract

Abstract: Latent autoimmune diabetes in adults (LADA) is an autoimmune disease that shares some genetic, immunological and clinical features with both type 1 diabetes and type 2 diabetes. Immune cells including CD4 + T cells, CD8 + T cells, B cells, macrophages and dendritic cells (DCs) have been detected in the pancreas of patients with LADA and a rat model of LADA. Therefore, similar to type 1 diabetes, the pathogenesis of LADA may be caused by interactions between islet β‐cells and innate and adaptive immune cells. However, the role of the immunity in the initiation and progression of LADA remains largely unknown. In this review, we have summarized the potential roles of innate immunity and immune‐modulators in LADA development. Furthermore, we have examined the evidence and discussed potential innate immunological reasons for the slower development of LADA compared with type 1 diabetes. More in‐depth mechanistic studies are needed to fully elucidate the roles of innate immune‐associated genes, molecules and cells in their contributions to LADA pathogenesis. Undertaking these studies will greatly enhance the development of new strategies and optimization of current strategies for the diagnosis and treatment of the disease.